Malignant Melanoma

  • Beata Imko-Walczuk
  • Richard Turner
  • Fenella Wojnarowska
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

Cutaneous malignant melanoma is a highly malignant tumour of the skin and is responsible for more deaths than any other skin cancer. Malignant melanoma arises from the malignant transformation of melanocytes at the dermal–epidermal junction or from the nevomelanocytes of melanocytic nevi that become invasive and may metastasise.


Transplant Recipient Skin Cancer Renal Transplant Recipient Organ Transplant Recipient Melanocytic Nevus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Imko-Walczuk B, et al. Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study. Author reply. Br J Dermatol 2007; 156(1):167–9.CrossRefGoogle Scholar
  2. 2.
    Braun-Falco O, et al. Dermatology, 2nd edn. Berlin: Springer-Verlag, 2000.Google Scholar
  3. 3.
    Dicker TJ, et al. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol 1999; 140(2):249–54.PubMedCrossRefGoogle Scholar
  4. 4.
    Lindelof B, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143(3):513–9.PubMedGoogle Scholar
  5. 5.
    Jensen P, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40(2 pt 1):177–86.PubMedCrossRefGoogle Scholar
  6. 6.
    Jain A, et al. Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 1998; 30(4):1403–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Le Mire L, et al. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154(3):472–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Brown VL, et al. Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study. Br J Dermatol 2007; 156(1):165–7; author reply 167–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Laing ME, et al. Malignant melanoma in transplant patients: review of five cases. Clin Exp Dermatol 2006; 31(5):662–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Moloney FJ, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154(3):498–504.PubMedCrossRefGoogle Scholar
  11. 11.
    Hollenbeak CS, et al. Increased incidence of melanoma in renal transplantation recipients. Cancer (Phila) 2005; 104(9):1962–7.CrossRefGoogle Scholar
  12. 12.
    Thomson MA, et al. Skin surveillance of a U.K. paediatric transplant population. Br J Dermatol 2007;156(1):45–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Euvrard S, et al. Skin cancers following pediatric organ transplantation. Dermatol Surg 2004; 30(4 pt 2):616–21.PubMedCrossRefGoogle Scholar
  14. 14.
    Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant 1998; 2(1):56–63.PubMedGoogle Scholar
  15. 15.
    Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61(2):274–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Leveque L, et al. Melanoma in organ transplant patients. Ann Dermatol Venereol 2000; 127(2):160–5.PubMedGoogle Scholar
  17. 17.
    Bouwes Bavinck JN, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61(5):715–21.PubMedCrossRefGoogle Scholar
  18. 18.
    Matin RN, Mesher D, Proby CM, et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant 2008; 8(9):1891–1900.PubMedCrossRefGoogle Scholar
  19. 19.
    Penn I. Transmission of cancer from organ donors. Ann Transplant 1997; 2(4):7–12.PubMedGoogle Scholar
  20. 20.
    Sheil AG. Donor-derived malignancy in organ transplant recipients. Transplant Proc 2001; 33(1–2):1827–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Stephens JK, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000; 70(1):232–6.PubMedGoogle Scholar
  22. 22.
    Buell JF, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery (St. Louis) 2001; 130(4):660–6; discussion 666–8.CrossRefGoogle Scholar
  23. 23.
    Morris-Stiff G, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004; 4(3):444–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70(12):1747–51.PubMedCrossRefGoogle Scholar
  25. 25.
    Loren AW, et al. Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation 2003; 76(4):741–3.PubMedCrossRefGoogle Scholar
  26. 26.
    Balch CM, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19(16):3635–48.PubMedGoogle Scholar
  27. 27.
    Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal- transplant recipients. Lancet 1981; 1(8231):1196–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Beata Imko-Walczuk
    • 1
  • Richard Turner
    • 2
  • Fenella Wojnarowska
    • 3
  1. 1.Clinical Department of Plastic Surgery and Burns TreatmentMedical Academy of Gdansk ulPoland
  2. 2.Department of DermatologyThe Churchill, HeadingtonOxfordUnited Kingdom
  3. 3.Department of DermatologyRadcliff Hospital, University of OxfordOxfordUnited Kingdom

Personalised recommendations